Cite
HARVARD Citation
O'Halloran, J. et al. (n.d.). LB1531B. Administration of the TNF-alpha inhibitor, infliximab, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial. Open forum infectious diseases. p. . [Online].